Related Experiment Videos
Alopecia associated with zidovudine therapy
S M Geletko1, M Segarra, D J Mikolich
1Department of Pharmacy Practice, University of Rhode Island College of Pharmacy, Providence, 02908, USA.
Pharmacotherapy
|January 1, 1996
Summary
Alopecia areata, a hair loss condition, can occur in individuals with human immunodeficiency virus (HIV). Zidovudine treatment may trigger or reverse this hair loss, as seen in one patient.
Area of Science:
- Dermatology
- Virology
- Pharmacology
Background:
- Alopecia is a known condition in patients with human immunodeficiency virus (HIV).
- Zidovudine, an antiretroviral medication, has been anecdotally reported to affect hair growth in HIV-infected individuals.
- The specific relationship between zidovudine and alopecia areata requires further investigation.
Observation:
- A 33-year-old male patient with HIV developed alopecia areata.
- The onset of alopecia areata coincided with the initiation of zidovudine therapy.
- The patient's hair loss condition showed improvement upon discontinuation of zidovudine.
Findings:
- Zidovudine therapy was associated with the development of alopecia areata in an HIV-infected patient.
- Cessation of zidovudine led to the reversal of alopecia areata.
- This case suggests a potential causal link between zidovudine and alopecia areata.
Implications:
- Clinicians should consider zidovudine as a potential trigger for alopecia areata in HIV patients.
- Monitoring for hair loss is recommended during zidovudine treatment.
- Further research is warranted to elucidate the mechanisms underlying zidovudine-induced alopecia.